EM·DRUGS

Coming soon

The first and definite website focused in emergency medicine drugs, giving answers about critical care medications and their indications, doses, preparations, literature evidence reviews and more.

Alpha version launching in late 2021 (Spanish and English!)

Excited to contribute to Emergency Medicine Education and diffusion of practical and relevant clinical pharmacology!

Cristóbal Sáa, MD
Emergency Medicine
Santiago, Chile

CORE CONTENT ABOUT COMMON CRITICAL CARE DRUGS

SNEAK·PEEK: Fibrinolytic Therapy
(English Slide 1, Spanish Slide 2)

Alteplase (tPA)
e.g. Actilyse®
50mg lyophilized powder

Tenecteplase (TNK)
e.g. Metalyse®
50mg lyophilized powder

Fibrinolysis

Updates coming, enjoy!

EM·DRUGS

2021 EM Drugs. All rights reserved.

DISCLAIMER

This website provides general information and discussion about medications, health, and related subjects. The words and other con­tent pro­vided in this website, and in any linked mate­ri­als, are not intended and should not be con­strued as med­ical advice. If the reader or any other per­son has a med­ical con­cern, he or she should con­sult with an appropriately-licensed physi­cian or other legally accredited health care worker in the country that resides or is visiting.

Please do not delay your medical concerns and potential health emergencies by searching information in this website, instead look out for medical opinion in the services that exist with that specific purpose and work under the respective local health-care regulations.

The views expressed on this blog and web­site have no rela­tion to those of any academic, hospital, practice or other insti­tu­tion with which the authors are affiliated.

For other instances, the authors of this website do not have any conflict of interest with any institution or pharmaceutical company in particular, and do not receive any compensation about any licenced drug mentioned in the website. In the same matter, the website is not intended to recommend any specific patented medication.


EM Drugs Team